RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
Media / Product Information / TecentriqÂ® (atezolizumab) TECENTRIQ is a cancer immunotherapy, which is a medicine designed to work with the body's own immune system. It is a monoclonal antibody designed to bind with programmed death-ligand 1 (PD-L1). PD-L1 is a protein that plays a role in preventing the body's immune system from fighting cancer.